期刊文献+

Tca8113-4-1BBL细胞联合CD28单抗在口腔鳞癌免疫治疗中的作用 被引量:1

Antitumor immunotherapy induced by Tca8113-4-1BBL cell combined with anti-CD28 mAb:An in vitro study
原文传递
导出
摘要 目的:探讨转4-1BBL肿瘤细胞联合抗CD28单抗体外诱导抗肿瘤活性的能力。方法:通过脂质体法将重组载体pEGFP/neo-h4-1BBL转染人舌鳞癌细胞Tca8113,经G418(400μg/mL)筛选及有限稀释后,获得稳定高表达克隆,分别用RT-PCR和Western印迹检测转染细胞中h4-1BBLmRNA和蛋白的表达。将转染与未转染4-1BBL基因的Tca8113细胞用丝裂霉素C(MMC)处理后,制成肿瘤细胞瘤苗。联合抗CD28单克隆抗体与经体外抗CD3mAb诱导的人外周血T淋巴细胞共同培养,测定T细胞增殖、CTL杀伤活性及产生细胞因子(IL-2和IFN-γ)的能力。实验数据以SPSS12.0软件包进行方差分析。结果:h4-1BBL基因真核表达载体在Tca8113细胞中获得稳定表达。转染h4-1BBL基因的Tca8113细胞联合抗CD28单抗能显著刺激T细胞活化、增殖(P<0.01),促进IL-2、IFN-γ分泌(P<0.01),并能有效地诱导CTL的特异性杀伤活性(P<0.01)。结论:转4-1BBL肿瘤细胞联合抗CD28抗体能显著增强肿瘤细胞的免疫原性,诱导T细胞产生有效的抗肿瘤免疫应答。 PURPOSE: To explore the effect on activation and cytotoxicity of human peripheral blood T lymphocyte induced by anti-CD28 mAb with h4-1BBL gene transfected into Tca8113 cells in vitro. METHODS: The eukaryotic expression vector pEGFP/neo-h4-1BBL was transfected into human tongue squamous cell carcinoma cells line Tca8113 by lipofectamine2000. Then the transfected cells were selected in medium containing G418 (400μg/mL), cloned by limited dilution and named as Tca8113-4-1BBL. Human 4-1BBL mRNA and protein expression of transfected cells was detected by RT-PCR and Western blot, respectively. The tumor cell vaccines (TCV)were obtained by treatment with mitomycin (MMC). The TCV were co-cultivated with anti-CD3 activated T lymphocytes with or without anti-CD28.Then the cytotoxic activity of CTL and the cytokines production (IFN-γ and IL-2) were tested. SPSS12.0 software package was used for statistical analysis. RESULTS: The Tca8113 cells transfected by pEGFP-h4-1BBL could express human 4-1BBL efficiently. As compared with wild typical Tca8113 cells, the anti-CD28 mAb with transfected Tca8113 cells had more effect for proliferation, IL-2, IFN-7 production and cytotoxie activity of lymphocytes. CONCLUSIONS: The anti-CD28 mAb with Tca8113 ceils transfected with 4-1BBL is effective in enhancing its immunogenicity and inducing antitumor immune response.
出处 《中国口腔颌面外科杂志》 CAS 2009年第5期446-450,共5页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金(30672335) 广东省自然科学基金(06027977) 深圳市科技局重点基金(200601008)~~
关键词 4-1BBL 抗CD28单克隆抗体 抗肿瘤免疫 细胞毒性T细胞 4-1BB ligand Anti-CD28 mAb Anti-tumor immunity Cytotoxic T lymphocyte
  • 相关文献

参考文献13

  • 1Lensehow DJ, Walunas TL, Bluestone JA, et al. CD28/B7 system Of T cell costimulation [J].Ann U Rev lmmunol,1996,14 (2):233- 237.
  • 2Chambers CA, Allison JP. Co-stimulation in T cell responses [J]. Curr Opin Immunol, 1997, 9(3):396-399.
  • 3Vinay DS, Kwon BS. Role of 4-1BB in immune responses[J]. Sere Immunol, 1998,10(6):481-489.
  • 4Costello RT, Fmallet D, Sainty D, et al. Regulation of CD80/B7- 1 and CD86/B7-2 molecular expression in human primary acute myeloid leukemia and their role in allogenic immune recognition [J]. Eur J Immunol, 1998, 28(1):90-98.
  • 5孙顺涛,杨宏宇,罗娟,储眉,张键荣,张立兵,桂耀庭.人共刺激分子4-1BBL表达载体的构建及转染Tca8113细胞的研究[J].中国口腔颌面外科杂志,2008,6(3):188-193. 被引量:2
  • 6Bertram EM, Lau P, Watts TH, et al. Temporal segregation of 4- 1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection [J]. J Immunol, 2002, 168 (8):3777-3785.
  • 7Cannons JL, Lau P, Ghumman B, et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy [J]. J Immunol, 2001, 167 (3):1313-1324.
  • 8Mazur MA, Davis CC, Szabolcs P. Ex vivo expansion and Thl/Tcl maturation of umbilical cord blood T cells by CD3/CD28 costimulation[J]. Biol Blood Marrow Transplant,2008,14(10):1190- 1196.
  • 9Lenschow DJ, Herold KC, Rhee L, et al. CD28/B7 regulation of Thl and Th2 subsets in the development of autoimnmne diabetes [J]. Immunity, 1996,5(3):285-293.
  • 10Linsley PS, Bradshaw J, Urnes M, et al. CD28 engagement by B7/ BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling [J]. J Immunol, 1993,150(8 Pt 1):3161-3169.

二级参考文献33

  • 1Iiaacs A, Lindenmann J. Virus interference. Ⅰ. The interferon[J]. Proc R Soc Lond B Biol Sci, 1957, 147(927) : 258-267.
  • 2Pestka S, Krause C D, Walter M R. Interferons, interferonlike cytokines, and their receptors[J]. Immunol Rev, 2004, 202:8-32.
  • 3Takaoka A, Yanai H. Interferon signalling network in innate defence[J]. Cell Microbiol, 2006, 8(6):907-922.
  • 4Oritani K, Medina K L, Tomiyama Y, et al. Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors[J]. Nat Med, 2000, 6(6): 659-666.
  • 5Tayal V, Kalra B S. Cytokines and anti-cytokines as therapeutics- An update[J]. European J Pharmacol, 2008, 579 (1-3):1-12.
  • 6Kotenko S V, Gallagher G, Baurin V V, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex[J]. Nat Immunol, 2003, 4(1): 69-77.
  • 7Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class Ⅱ cytokuine receptor IL-28R[J]. Nat Immunol, 2003, 4(1):63-68.
  • 8Chelbi-Alix M K, Wietzerbin J. Interferon, a growing cytokine family : 50 years of interferon research[J]. Biochimie, 2007, 89 (6-7):713-718.
  • 9Tan X M, Tang Y,Yang Y F, et al. Cloning, sequencing, expression and biological activity of giant panda (Ailuropoda rnelanoleuca) interferon-α[J]. Molecular Immunol, 2007, 44 (11):3061-3069.
  • 10Wonderling R, Powell T, Baldwin S, et al. Cloning, expression, purification, and biological activity of five feline type Ⅰ interferons[J]. Vet Immunol Immunopathol, 2002,89 ( 1-2 ):13-27.

共引文献5

同被引文献15

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部